Company: REVB
Filing Date: 2025-07-09
Form Type: 8-K
Source: 0000950170-25-094789
Chunk: 2

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-07-09
Form: 8-K
Item: Item 5.03
Chunk 2
---
 which result in changes to the exercise prices (and in the case of the Class G Common Stock Warrants, to the number of shares for which they are exercisable) based upon the VWAP of the Company’s common stock in the days before and/or following the effected Reverse Stock Split. Furthermore, the number of shares of common stock available for issuance under the Company’s equity incentive plans were proportionately adjusted for the Reverse Stock Split ratio, such that fewer shares are subject to such plans.

The new CUSIP number for common stock following the Reverse Stock Split is 76135L705. For more information about the Reverse Stock Split, see the Company’s definitive proxy statement filed with the Securities and Exchange Commission on June 9, 2025.

The text of the Certificate of Amendment is filed as Exhibit 3.1 and incorporated herein by reference.

Item 8.01 Other Events.